Skip to main content
U.S. flag

An official website of the United States government

Lactobacillus Spp.-enhanced memory is strain-dependent and associated, in part, with amyloidogenic and anti-oxidant/oxidative stress interplay in amyloid beta precursor protein transgenic mice

Bibliographic

Year of Publication:
2022
Contact PI Name:
Kalavathy Ramasamy
Contact PI Affiliation:
Collaborative Drug Discovery Research (CDDR) Group, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM ) Cawangan Selangor, Kampus Puncak Alam, Selangor Darul Ehsan, Malaysia
Co-Authors:
Nor Amalina Ahmad Alwi, Siong Meng Lim, Vasudevan Mani
Primary Reference (PubMED ID):
Funding Source:
Ministry of Higher Education (MOHE) Malaysia
Study Goal and Principal Findings:

This study explored mechanisms underpinning enhanced memory in amyloid precursor protein (APP) transgenic mice (male; 10-12 months; n = 6/group) supplemented with Lactobacillus plantarum LAB12 (LAB12)/Lactobacillus casei Shirota (LcS). Morris Water Maze test was performed before brains were harvested for gene expression and biochemical studies. LAB-supplemented mice exhibited reduced escape latency and distance but significant increased time spent in platform zone. This was associated with downregulated beta-site APP cleaving enzyme-1 (BACE1) mRNA and significant reduced nitric oxide in brains. LAB12 also significantly increased glutathione. The LAB-enhanced memory is strain-dependent and could be mediated, in part, through amyloidogenic pathway and anti-oxidant/oxidative stress interplay.

Bibliographic Notes:
Nor Amalina Ahmad Alwi and Siong Meng Lim contributed equally to this work.

Therapeutic Agent

Therapeutic Information:
Therapy Type:
Biologic - Microbiota
Therapeutic Agent:
Lactobacillus plantarum (LAB12)
Therapeutic Target:
Multi Target
Therapy Type:
Biologic - Microbiota
Therapeutic Agent:
Lactobacillus casei (LcS)
Therapeutic Target:
Multi Target

Animal Model

Model Information:
Species:
Mouse
Model Type:
APP
Strain/Genetic Background:
C57BL/6J
Species:
Mouse
Model Type:
Non-transgenic
Strain/Genetic Background:
C57BL/6J

Experimental Design

Is the following information reported in the study?:
Power/Sample Size Calculation
Randomized into Groups
Blinded for Treatment
Blinded for Outcome Measures
Pharmacokinetic Measures
Pharmacodynamic Measures
Toxicology Measures
ADME Measures
Biomarkers
Dose
Formulation
Route of Delivery
Duration of Treatment
Frequency of Administration
Age of Animal at the Beginning of Treatment
Age of Animal at the End of Treatment
Sex as a Biological Variable
Study Balanced for Sex as a Biological Variable
Number of Premature Deaths
Number of Excluded Animals
Statistical Plan
Genetic Background
Inclusion/Exclusion Criteria Included
Conflict of Interest

Outcomes

Outcome Measured
Outcome Parameters
Behavioral
Morris Water Maze
Motor Function
Swimming Speed
Biochemical
Amyloid Precursor Protein (APP) mRNA
beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) mRNA
Acetylcholine Levels
Acetylcholinesterase (AChE) Activity
Superoxide Dismutase (SOD)
Catalase (CAT)
Glutathione (GSH)
Glutathione Peroxidase (GPx)
Nitric Oxide (NO)
Interferon (IFN) gamma
Interleukin 1 beta (IL-1 beta)
Interleukin 6 (IL-6)
Interleukin 10 (IL-10)